Mixed results from latest study of BenevolentAI's dermatitis ointment
An ointment for patients with mild to moderate skin disease, atopic dermatitis (AD), has had mixed results from its phase 2a study.
Archives for April 6, 2023
Avacta opens two US sites and doses first patient in sarcoma drug trial
TWO US clinical investigator sites have been opened for a phase 1 clinical trial for patients with soft tissue sarcoma and the first patient has been dosed.
Mirum Pharmaceuticals success with study of drug for chronic liver disease
A small molecule drug to treat a chronic liver disease has been proven to support treatment across the broadest range of genetic types ever studied.